This page lists the SEC filings reported by Endurant Capital Management LP.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-04-10 | Endurant Capital Management LP | INVACARE HOLDINGS Corp | 41,150,068 | 66.8% | EDGAR |
SC 13D/A | 2023-09-08 | Endurant Capital Management LP | INVACARE HOLDINGS Corp | 39,488,569 | 84.9% | EDGAR |
SC 13D | 2023-05-15 | Endurant Capital Management LP | INVACARE HOLDINGS Corp | 2,986,092 | 29.9% | EDGAR |
SC 13G/A | 2023-03-21 | Endurant Capital Management LP | AZIYO BIOLOGICS, INC. | 576,253 | 4.9% | EDGAR |
SC 13G/A | 2023-02-14 | Endurant Capital Management LP | AZIYO BIOLOGICS, INC. | 1,259,544 | 10.7% | EDGAR |
SC 13G/A | 2023-02-14 | Endurant Capital Management LP | AZIYO BIOLOGICS, INC. | 1,259,544 | 10.7% | EDGAR |
SC 13G/A | 2022-02-14 | Endurant Capital Management LP | AZIYO BIOLOGICS, INC. | 1,075,640 | 11.7% | EDGAR |
SC 13G | 2021-06-09 | Endurant Capital Management LP | AZIYO BIOLOGICS, INC. | 873,159 | 12.3% | EDGAR |
SC 13G/A | 2021-02-17 | Endurant Capital Management LP | Oxford Immunotec Global PLC | 0 | 0.0% | EDGAR |
SC 13G | 2021-02-12 | Endurant Capital Management LP | Oxford Immunotec Global PLC | 2,240,421 | 8.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.